Kalkine has a fully transformed New Avatar.
Last update at 2025-06-18T03:41:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Global Expansion, New Sector Advance Alexium Year-End Goals
Mon 15 Aug 16, 01:04 PMAlexium to Provide Chemistry for Global Tent Supplier
Thu 14 Jul 16, 01:12 PMChemiplas Appointed Sole Distributor for Australia
Tue 14 Jun 16, 03:09 PMAlexium CEO Nicholas Clark Joins American Security Project Board of Directors
Tue 31 May 16, 02:37 PMAlexiflam Chemistry Expands to Second Major Bedding Brand
Fri 16 Oct 15, 06:14 PMMajor Bedding Customer Continues Expansion of Alexiflam(TM) FR Chemistry
Wed 26 Aug 15, 07:00 PMAlexium's $1.10 Price Target Maintained by Sydney Broker
Mon 03 Aug 15, 08:53 PMBreakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Income before tax | -2.95094M | -3.36027M | -1.44532M | -6.12548M | -6.12548M |
Minority interest | - | - | - | - | - |
Net income | -2.95094M | -4.13631M | -5.00338M | -7.98031M | -8.00783M |
Selling general administrative | 2.87M | 2.46M | 2.99M | 3.05M | 3.05M |
Selling and marketing expenses | 0.52M | 0.85M | 1.06M | 0.94M | 0.94M |
Gross profit | 2.82M | 3.33M | 2.64M | 2.31M | 2.66M |
Reconciled depreciation | 0.66M | 1.05M | 0.91M | 0.04M | 0.04M |
Ebit | -2.04561M | -1.55785M | -0.76345M | -4.24312M | -4.24312M |
Ebitda | -1.38137M | -0.51127M | 0.15M | -4.21737M | -3.62880M |
Depreciation and amortization | 0.66M | 1.05M | 0.91M | 0.03M | 0.61M |
Non operating income net other | - | - | - | - | - |
Operating income | -3.30020M | -1.55785M | 0.15M | -4.24312M | -4.24312M |
Other operating expenses | 0.62M | 10.42M | 10.92M | 10.31M | 10.90M |
Interest expense | 0.91M | 0.78M | 0.68M | 1.88M | 1.88M |
Tax provision | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
Interest income | 0.19M | 0.00218M | 0.00658M | 1.91M | 2.16M |
Net interest income | -0.97058M | -0.77386M | -0.67528M | -2.74276M | -3.94409M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 1.12M | 0.78M | 3.56M | 1.85M | 1.88M |
Total revenue | 7.21M | 8.17M | 7.28M | 6.08M | 6.42M |
Total operating expenses | 5.02M | 5.58M | 6.29M | 6.55M | 7.14M |
Cost of revenue | 4.39M | 4.85M | 4.63M | 3.77M | 3.77M |
Total other income expense net | 0.22M | -1.80242M | -1.59284M | -1.88236M | -1.88236M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -2.95094M | -3.36027M | -1.44532M | -8.92536M | -9.89522M |
Net income applicable to common shares | -2.95094M | -3.36027M | -1.44532M | -6.12548M | -6.93952M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
Total assets | 5.23M | 5.38M | 6.42M | 10.48M | 11.67M |
Intangible assets | 0.76M | 1.70M | 1.57M | 2.96M | 2.68M |
Earning assets | - | - | - | - | - |
Other current assets | 0.07M | 0.09M | 0.09M | 0.07M | 0.04M |
Total liab | 1.93M | 6.36M | 4.85M | 6.30M | 6.24M |
Total stockholder equity | 3.30M | -0.98314M | 1.58M | 4.18M | 5.43M |
Deferred long term liab | - | 1.70M | 1.57M | 2.96M | 2.67M |
Other current liab | 0.60M | 0.42M | 0.41M | 0.56M | 0.67M |
Common stock | 73.59M | 66.61M | 66.52M | 66.27M | 65.94M |
Capital stock | - | 66.61M | 66.52M | 66.27M | 65.94M |
Retained earnings | -69.08650M | -66.61948M | -63.75247M | -60.39220M | -59.58901M |
Other liab | - | 0.69M | 0.18M | 0.95M | 1.81M |
Good will | - | - | - | - | - |
Other assets | - | 1.71M | 1.59M | 2.96M | 2.67M |
Cash | 2.05M | 0.51M | 1.03M | 2.93M | 4.74M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 1.48M | 1.29M | 1.11M | 1.97M | 1.04M |
Current deferred revenue | - | - | - | - | - |
Net debt | -1.68435M | 4.17M | 2.82M | 0.53M | -1.21448M |
Short term debt | 0.37M | 0.30M | 0.30M | 0.08M | 0.14M |
Short long term debt | - | 0.16M | 0.18M | - | - |
Short long term debt total | 0.37M | 4.69M | 3.85M | 3.46M | 3.53M |
Other stockholder equity | - | -1.60441M | -1.27963M | -1.77874M | -1.76688M |
Property plant equipment | - | 1.20M | 1.54M | 1.90M | 2.29M |
Total current assets | 3.58M | 2.47M | 3.30M | 5.60M | 6.68M |
Long term investments | - | 0.02M | 0.02M | - | 0.03M |
Net tangible assets | - | -0.98314M | 1.58M | 4.18M | 5.42M |
Short term investments | - | - | - | - | - |
Net receivables | 0.90M | 1.05M | 0.58M | 1.37M | 0.98M |
Long term debt | - | 3.79M | 2.82M | 2.51M | 2.44M |
Inventory | 0.56M | 0.82M | 1.60M | 1.22M | 0.92M |
Accounts payable | 0.52M | 0.57M | 0.41M | 1.33M | 0.23M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -1.20530M | -0.97443M | -1.19570M | -1.69480M | -0.92724M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | 96.09M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 0.00000M | - | 0.02M | 0.02M | 0.02M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 1.65M | 2.91M | 3.13M | 4.88M | 4.99M |
Capital lease obligations | - | 0.74M | 0.86M | 0.95M | 1.58M |
Long term debt total | - | 4.39M | 3.55M | 3.38M | 3.39M |
Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Investments | -0.38654M | -0.35482M | -0.88155M | -1.74867M | -1.62247M |
Change to liabilities | 0.00000M | 0.00000M | 1.14M | -0.70830M | 0.62M |
Total cashflows from investing activities | -0.38654M | -0.35482M | -0.88155M | -1.20012M | -1.13784M |
Net borrowings | 1.00M | 0.14M | 0.33M | -5.51579M | -1.25870M |
Total cash from financing activities | 1.00M | 0.07M | 0.32M | 5.51M | 5.51M |
Change to operating activities | 0.02M | 0.20M | -0.08887M | -0.00080M | 0.47M |
Net income | -2.95094M | -4.13631M | -1.44532M | -8.91471M | -9.90880M |
Change in cash | -0.51382M | -1.90558M | -1.80858M | 0.90M | 0.90M |
Begin period cash flow | 1.03M | 2.93M | 4.74M | 3.84M | 3.84M |
End period cash flow | 0.51M | 1.03M | 2.93M | 4.74M | 4.74M |
Total cash from operating activities | -1.10360M | -3.08973M | -1.39177M | -3.17514M | -3.17514M |
Issuance of capital stock | - | - | - | 11.77M | 11.77M |
Depreciation | 0.36M | 1.05M | 0.91M | 0.04M | 0.04M |
Other cashflows from investing activities | -0.36778M | -0.30244M | -0.00000M | -1.09783M | -0.06000M |
Dividends paid | - | - | - | 4.07M | 4.07M |
Change to inventory | 0.77M | -0.37513M | -0.30253M | 0.23M | 0.36M |
Change to account receivables | -0.30849M | -0.26129M | -0.38791M | -0.01766M | -0.44822M |
Sale purchase of stock | -0.00094M | -0.00428M | 0.00000M | -0.63450M | -0.63450M |
Other cashflows from financing activities | 6.68M | 0.19M | 0.47M | 8.03M | 8.03M |
Change to netincome | 0.70M | 1.18M | -1.21475M | 2.86M | 1.24M |
Capital expenditures | 0.39M | 0.35M | 0.89M | 1.20M | 1.20M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | 0.01M | 0.00217M | 0.00559M | 0.02M | 0.03M |
Stock based compensation | - | - | - | - | - |
Other non cash items | - | 3.09M | 0.53M | 8.88M | 9.87M |
Free cash flow | -1.49014M | -3.44455M | -2.27826M | -4.37568M | -4.37568M |
Sector: Basic Materials Industry: Specialty Chemicals
Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
AJX Alexium International Group |
- -% | 0.007 | - | - | 2.05 | 4.17 | 1.35 | -8.4553 |
ORI Orica Ltd |
-0.26 1.35% | 18.93 | 100.08 | 15.22 | 1.17 | 2.06 | 1.45 | 11.12 |
DNL Dyno Nobel Limited. |
-0.06 2.19% | 2.68 | - | 11.34 | 0.92 | 1.02 | 1.41 | 36.31 |
5EA 5E Advanced Materials Inc DRC |
-0.01 1.85% | 0.53 | - | - | 17125.18 | 1.22 | -5.7034 | |
DGL DGL Group Ltd |
-0.01 2.63% | 0.37 | 20.00 | 10.00 | 0.23 | 0.33 | 0.57 | 4.99 |
Alexium International Group Limited manufactures and sells phase-change material (PCM) and other specialty textile solutions in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; and Eclipsys, a perpetual cooling technology that enhance the cooling experience. The company also provides flame retardant solutions, such as Alexiflam, a flame-retardant treatment for military fabrics; DelCool, a thermal management product; Alexiguard supplemental treatment. It serves bedding, body armour, military uniform, and workwear markets; and for textile and foam applications. The company is based in Greer, South Carolina.
350 West Phillips Road, Greer, SC, United States, 29650
Name | Title | Year Born |
---|---|---|
Mr. Jason Lewis | Chief Financial Officer | NA |
Dr. Robert Brookins B.A., B.Sc., Ph.D. | CTO & Exec. Director | NA |
Mr. William Timothy Blackburn | CEO & Managing Director | NA |
Mr. Mark Wise | VP of Investor Relations & Corp. Communications | NA |
Ms. Maja Aleksandra McGuire | Gen. Counsel | NA |
Mr. Scott Hunter | VP of Sales | NA |
Ms. Jessica Hutchison | VP of HR | NA |
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP | Company Sec. | 1964 |
Dr. Robert Brookins B.A., B.Sc., Ph.D. | CTO & Executive Director | NA |
Dr. Robert Brookins B.A., B.Sc., Ph.D. | CTO & Executive Director | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.